Life Science Investing Ambrx Biopharma Inc. Reports 1H 2022 Financial Results and Provides Corporate Update
Medical Device Investing New Data Show Abbott's HeartMate 3 Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients
Medical Device Investing ALR Technologies Announces Update on the GluCurve Pet CGM Distribution and Commercialization
AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology 2022 Congress
Pharmaceutical Investing Merck to Present New Data at ESMO 2022 Congress From Its Broad Oncology Portfolio and Promising Pipeline, Demonstrating Commitment to Improving Long-Term Survival in Multiple Types of Cancer
NEW AMGEN DATA AT ESC 2022 SHOW LONG-TERM LDL-C LOWERING WITH REPATHA® WAS WELL-TOLERATED FOR MORE THAN 8 YEARS
Medical Device Investing Medtronic Extravascular ICD meets global pivotal clinical trial's safety and effectiveness endpoints
Late-Breaking Results From Phase 2 AXIOMATIC-SSP Study of Milvexian, an Investigational Oral Factor XIa Inhibitor, Show Favorable Antithrombotic Profile in Combination With Dual Antiplatelet Therapy
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
